Nelson Lugo has over twenty five years’ of experience in the areas of biopharmaceutical process development and manufacturing. He most recently served as Senior Director, Manufacturing and San Diego Site Lead for AstraZeneca PLC. He is currently consulting on early to late stage technology transfer and manufacturing implementation programs.
Mr. Lugo has worked in process scale-up, development and manufacturing of products derived from multiple sources including plasma proteins, recombinant antigens, antibodies, synthetic peptides and small molecules. He has managed the technology transfer of products from R&D into the Commercial space as well as overseen multiple contract CMOs for DS (API), fill/finish operations including vial, cartridges, syringes, pen assembly and secondary packaging sites.
He has managed the technology transfer of products from Development to Manufacturing at XOMA (US) LLC, Scios, Inc., and Amylin Pharmaceuticals, Inc. He’s directed the manufacturing operations for Melville Biologics, Dendreon Corporation and ISTA Pharmaceuticals, Inc.
He has been a guest lecturer at the University of California, Berkeley covering issues in process development and manufacturing. He is also the author of a chapter on “Aseptic Processing of Biopharmaceuticals”.
Mr. Lugo received his Bachelor’s degree in Clinical Chemistry from York College, New York and holds an MBA from Adelphi University, New York.